YHN Acquisition I Limited Announces Closing of $60,000,000 Initial Public Offering
YHN Acquisition I Limited (the "Company") announced today the closing of its initial public offering of 6,000,000 units at $10.00 per unit (the "Offering").
Rezolute, Inc.: Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update
FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in the U.S. Phase 3 study for ersodetug for the treatment of tumor HI expected to com ...
Eli Lilly - LLY: Fettweg-Killer laufen besser als bei Novo Nordisk!
Mounjaro, Zepbound & Verzenio glänzen im Quartalsbericht bei Eli Lilly (LLY)! Der Pharmariese hebt die Jahresziele für Umsatz ...
Finanznachrichten12m
Norges Bank - Form 8.3 - International Paper Company
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Norges Bank (b) Owner or controller of ...
Alliance Entertainment Reports Fourth Quarter and Fiscal Year 2024 Results
Operational efficiencies and margin improvements drive profitability turnaround Higher-margin DTC sales increased to 36% of gross revenue in FY24 Strengthened balance sheet with 45% reduction in revol ...
Village Super Market, Inc.: Village Super Market Announces Forthcoming Change in Chief Executive Officer and Chairman of the Board of Directors
Village Super Market, Inc. (NSD-VLGEA) today announced that Robert Sumas has notified the Board of Directors of his decision to step down as Chief ...
UniFirst Corporation Announces Leadership Changes: Kelly Rooney Named Chief Operating Officer and Michael Croatti to Transition from Executive Role
UniFirst Corporation (NYSE: UNF), a North American leader in the supply and servicing of uniform and workwear programs, facility service products ...
FedEx Reports First Quarter Diluted EPS of $3.21 and Adjusted Diluted EPS of $3.60
FedEx Corp. (NYSE: FDX) today reported the following consolidated results for the first quarter ended August 31 (adjusted measures exclude the item listed below): ...
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the Phase 2 clinical trial Results to be presented at the ...
Bright Green Corporation Provides an Update, Reinforces Commitment to Shareholders, and Focuses on Growth and Strategic Partnerships
Bright Green Corporation (Nasdaq: BGXX) ("Bright Green" or the "Company"), today announced that trading of its shares have been suspended from the ...
GENFIT S.A.: GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update
Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone invoiced in June 2024 (received in August 2024) upon first sale of Ipsen's Iqirvo® (elafibran ...
Biodexa Pharmaceuticals PLC: ADR Ratio Change
ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company ...